We're redesigning our website - we're keen for you to try it so we can hear your views on how it can be improved ahead of the official launch. Head on over to the HFEA BETA to see how it is shaping up.

PGD conditions awaiting consideration

Preimplantation genetic diagnosis (PGD) is a technique that enables people with a specific inherited condition in their family to avoid passing it on to their children. It involves checking the genes of embryos created through IVF for this genetic condition.

If a clinic wishes to use Preimplantation genetic diagnosis (PGD) to test for a new genetic condition, then it must apply to the HFEA for permission.

You can sign up to our PGD update email alert service which will keep you up to date, on a monthly basis, with information on the latest conditions added to the authorised list and conditions that are awaiting approval about which you can provide comments.

The following conditions are those which the HFEA is considering to allow clinics to use PGD to test for:

Genetic condition OMIM number1 Submit feedback to the HFEA by:
Cerebro-oculo-facial-skeletal syndrome type 3 616570 11/01/2017
Seizures, cortical blindness, microcephaly syndrome (SCBMS) 616632 11/01/2017
Leigh Syndrome; French Canadian type (LSFC) 220111 11/01/2017
Early Infantile Epileptic Encephalopathy-28 616211 12/12/2016
Familial Juvenile Hyperuricemic Nephropathy 1 (FJHN1) and Medullary Cystic Kidney Disease 2 (MCKD2) 603860 7/12/2016
Dopamine Responsive Dystonia (DRD) 128230 7/12/2016
Van der Woude syndrome 119300 7/12/2016
VICI syndrome 242840 Closed
Duane-radial ray syndrome 607323 Closed
Friedreich Ataxia 1 229300 Closed
Peutz-Jeghers syndrome 175200 Closed
Aicardi Goutieres syndrome type 2 (AGS2) 610181 Closed
Antithrombin III Deficiency 613118 Closed
Autosomal Dominant Hypocalcaemia 615361 and 601198 Closed
Mitochondrial complex 1 deficiency 252010 Closed

1- Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD),. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim

Have your say on conditions awaiting consideration

If you have any feedback on the genetic conditions awaiting consideration by the HFEA, send us an email and we will discuss your comments at the next Licence Committee.

Email your feedback to: pgd@hfea.gov.uk

You can also sign up to our PGD update email alert service which will keep you up to date, on a monthly basis, with information on the latest conditions added to the authorised list and conditions that are awaiting approval about which you can provide comments.

 

Page last updated: 26 July 2016